Total Payments
$8,965
2024 Payments
$1,843
Companies
49
Transactions
455
Medicare Patients
9,495
Medicare Billing
$842,554
Payment Breakdown by Category
Food & Beverage$8,444 (94.2%)
Education$262.65 (2.9%)
Other$257.63 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,444 | 437 | 94.2% |
| Education | $262.65 | 8 | 2.9% |
| Honoraria | $257.63 | 1 | 2.9% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$8,965
446 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,221 | 63 | $0 (2024) |
| Medtronic, Inc. | $1,018 | 60 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $834.47 | 45 | $0 (2024) |
| Axonics, Inc. | $620.72 | 18 | $0 (2024) |
| Janssen Biotech, Inc. | $602.44 | 31 | $0 (2024) |
| UROVANT SCIENCES INC | $521.83 | 40 | $0 (2022) |
| ABBVIE INC. | $382.62 | 20 | $0 (2024) |
| Allergan, Inc. | $335.85 | 12 | $0 (2021) |
| Endo Pharmaceuticals Inc. | $322.05 | 17 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $233.80 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,843 | 96 | Sumitomo Pharma America, Inc. ($438.70) |
| 2023 | $2,235 | 103 | Medtronic, Inc. ($523.53) |
| 2022 | $1,523 | 80 | UROVANT SCIENCES INC ($404.16) |
| 2021 | $756.49 | 43 | Astellas Pharma US Inc ($188.29) |
| 2020 | $257.60 | 12 | Endo Pharmaceuticals Inc. ($80.62) |
| 2019 | $1,100 | 48 | Astellas Pharma US Inc ($226.24) |
| 2018 | $592.20 | 37 | Astellas Pharma US Inc ($261.71) |
| 2017 | $658.02 | 36 | Astellas Pharma US Inc ($172.15) |
All Payment Transactions
455 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: UROLOGY | ||||||
| 11/28/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.34 | General |
| Category: UROLOGY | ||||||
| 11/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $0.30 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $65.91 | General |
| Category: Immunotherapy | ||||||
| 10/24/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: UROLOGY | ||||||
| 10/19/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $9.53 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/07/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: ONCOLOGY | ||||||
| 10/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: UROLOGY | ||||||
| 09/27/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 09/24/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/23/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Urology | ||||||
| 09/17/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $30.99 | General |
| Category: Sacral Nerve Stimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,606 | 3,603 | $1.1M | $237,503 |
| 2022 | 20 | 2,461 | 3,212 | $1.1M | $231,266 |
| 2021 | 19 | 2,254 | 3,047 | $811,227 | $196,962 |
| 2020 | 23 | 2,174 | 2,777 | $755,970 | $176,822 |
Total Patients
9,495
Total Services
12,639
Medicare Billing
$842,554
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 566 | 898 | $270,298 | $88,296 | 32.7% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 75 | 75 | $78,150 | $23,757 | 30.4% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Facility | 2023 | 82 | 120 | $106,200 | $15,501 | 14.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 129 | 129 | $51,760 | $15,256 | 29.5% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 79 | 79 | $50,560 | $13,426 | 26.6% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 118 | 130 | $54,730 | $11,783 | 21.5% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 169 | 201 | $53,265 | $9,543 | 17.9% |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | Facility | 2023 | 16 | 23 | $122,220 | $7,944 | 6.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 109 | 113 | $49,155 | $6,019 | 12.2% |
| 64566 | Insertion of lower leg neurostimulator electrode | Office | 2023 | 12 | 58 | $34,220 | $5,701 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 67 | 68 | $20,468 | $5,384 | 26.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 27 | 94 | $15,604 | $5,019 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 25 | $10,450 | $3,834 | 36.7% |
| 51715 | Injection of implant material beneath lining of bladder and/or urethra using an endoscope | Facility | 2023 | 19 | 23 | $16,790 | $3,641 | 21.7% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Facility | 2023 | 33 | 33 | $54,615 | $3,509 | 6.4% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 79 | 79 | $31,995 | $2,198 | 6.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 30 | $7,980 | $2,073 | 26.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 169 | 221 | $13,481 | $2,037 | 15.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 575 | 920 | $4,600 | $2,022 | 44.0% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 13 | 37 | $6,031 | $1,934 | 32.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 16 | 17 | $3,145 | $1,717 | 54.6% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Facility | 2023 | 49 | 49 | $31,360 | $1,651 | 5.3% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2023 | 21 | 32 | $8,320 | $1,515 | 18.2% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Facility | 2023 | 16 | 16 | $16,672 | $1,398 | 8.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 19 | 32 | $4,032 | $1,294 | 32.1% |
About Dr. Kelly Johnson, M.D
Dr. Kelly Johnson, M.D is a Urology healthcare provider based in Owings Mills, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1871732503.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kelly Johnson, M.D has received a total of $8,965 in payments from pharmaceutical and medical device companies, with $1,843 received in 2024. These payments were reported across 455 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($8,444).
As a Medicare-enrolled provider, Johnson has provided services to 9,495 Medicare beneficiaries, totaling 12,639 services with total Medicare billing of $842,554. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Owings Mills, MD
- Active Since 02/19/2009
- Last Updated 08/22/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1871732503
Products in Payments
- GEMTESA (Drug) $1,330
- INTERSTIM (Device) $1,213
- ERLEADA (Drug) $492.16
- Axonics (Device) $487.30
- BOTOX (Biological) $410.90
- ELIGARD (Drug) $383.16
- Myrbetriq (Drug) $368.45
- MYRBETRIQ (Drug) $352.64
- XIAFLEX (Biological) $274.12
- XTANDI (Drug) $249.43
- KEYTRUDA (Biological) $214.74
- PYLARIFY (Drug) $181.03
- ADSTILADRIN (Biological) $163.38
- Erleada (Drug) $148.82
- UROLIFT (Device) $138.74
- AVEED (Biological) $135.26
- Bulkamid (Device) $130.08
- Prolia (Biological) $117.18
- PROVENGE (Drug) $115.46
- Noctiva (Drug) $112.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.